Renaissance Capital LLC - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 180 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.

Quarter-by-quarter ownership
Renaissance Capital LLC ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q1 2023$59,996
-34.0%
7,957
-11.4%
0.04%
-38.0%
Q4 2022$90,927
-38.6%
8,976
-13.1%
0.07%
+86.8%
Q4 2021$148,000
-39.1%
10,327
-14.9%
0.04%
-22.4%
Q3 2021$243,000
-61.2%
12,142
-57.4%
0.05%
-50.5%
Q2 2021$627,000
-46.9%
28,491
-18.0%
0.10%
-43.4%
Q1 2021$1,180,00034,7610.18%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Founders Fund VII Management, LLC 3,773,530$37,320,00092.58%
Gruss & Co., LLC 308,570$3,052,00026.27%
Founders Fund Growth Management, LLC 407,017$4,025,00011.55%
Belmont Capital, LLC 510,000$5,044,0005.95%
HARVARD MANAGEMENT CO INC 4,105,095$40,599,0005.05%
GUARDIAN CAPITAL ADVISORS LP 3,736,414$40,129,0005.01%
Intellectus Partners, LLC 1,091,505$10,795,0003.84%
ArchPoint Investors 617,213$6,104,0002.49%
BRANDYWINE MANAGERS, LLC 56,976$563,0001.85%
Casdin Capital, LLC 1,650,000$16,319,0001.07%
View complete list of ABCELLERA BIOLOGICS INC shareholders